Please use this identifier to cite or link to this item: https://hdl.handle.net/11499/32226
Full metadata record
DC FieldValueLanguage
dc.contributor.authorIsik, U-
dc.contributor.authorKostek, O-
dc.contributor.authorDemiray, Gökçen-
dc.contributor.authorDirican, A-
dc.contributor.authorSimsek, M-
dc.contributor.authorBuyuksimsek, M-
dc.contributor.authorUcar, G-
dc.date.accessioned2020-06-08T13:42:41Z-
dc.date.available2020-06-08T13:42:41Z-
dc.date.issued2019-
dc.identifier.issn0732-183X-
dc.identifier.urihttps://hdl.handle.net/11499/32226-
dc.identifier.urihttps://doi.org/10.1200/JCO.2019.37.15_suppl.e16075-
dc.description.abstractAbstract Not Availableen_US
dc.language.isoenen_US
dc.publisherAMER SOC CLINICAL ONCOLOGYen_US
dc.relation.ispartofJOURNAL OF CLINICAL ONCOLOGYen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.titleReal life data from Turkey regarding the impact of first-line sunitinib and pazopanib in metastatic renal cell cancer.en_US
dc.typeConference Objecten_US
dc.identifier.volume37en_US
dc.identifier.issue15en_US
dc.identifier.doi10.1200/JCO.2019.37.15_suppl.e16075-
dc.relation.publicationcategoryKonferans Öğesi - Uluslararası - Kurum Öğretim Elemanıen_US
dc.identifier.wosWOS:000487345801503en_US
dc.identifier.scopusqualityQ1-
dc.ownerPamukkale University-
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeConference Object-
item.languageiso639-1en-
item.fulltextNo Fulltext-
crisitem.author.dept14.02. Internal Medicine-
Appears in Collections:Tıp Fakültesi Koleksiyonu
WoS İndeksli Yayınlar Koleksiyonu / WoS Indexed Publications Collection
Show simple item record



CORE Recommender

WEB OF SCIENCETM
Citations

1
checked on Nov 24, 2024

Page view(s)

30
checked on Aug 24, 2024

Google ScholarTM

Check




Altmetric


Items in GCRIS Repository are protected by copyright, with all rights reserved, unless otherwise indicated.